|
1
|
Chen C, Huang S, Huang A, Jia Y, Wang J,
Mao M, Zhou J and Wang L: Total endoscopic thyroidectomy versus
conventional open thyroidectomy in thyroid cancer: A systematic
review and meta-analysis. Ther Clin Risk Manag. 14:2349–2361. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Huang F, Zhang Q, Chen W, Zhang H, Lu G,
Chen J and Qiu C: Long noncoding RNA cancer susceptibility
candidate 2 suppresses papillary thyroid carcinoma growth by
inactivating the AKT/ERK1/2 signaling pathway. J Cell Biochem.
120:10380–10390. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu J, Wang Y and Zhang B: Advances in
diagnosis and treatment of thyroid cancer in children and
adolescents. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 40:838–842.
2018.(In Chinese). PubMed/NCBI
|
|
4
|
Davis PJ, Tang HY, Hercbergs A, Lin HY,
Keating KA and Mousa SA: Bioactivity of thyroid hormone analogs at
cancer cells. Front Endocrinol (Lausanne). 9:7392018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Albano D, Durmo R, Bertagna F and Giubbini
R: 18F-choline PET/CT incidental thyroid uptake in patients studied
for prostate cancer. Endocrine. 63:531–536. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bolf EL, Sprague BL and Carr FE: A linkage
between thyroid and breast cancer: A common etiology? Cancer
Epidemiol Biomarkers Prev. 28:643–649. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Enokida T and Tahara M: I. genomic
medicine in thyroid cancer. Gan To Kagaku Ryoho. 45:1711–1715.
2018.(In Japanese). PubMed/NCBI
|
|
8
|
Fu XM, Guo W, Li N, Liu HZ, Liu J, Qiu SQ,
Zhang Q, Wang LC, Li F and Li CL: The expression and function of
long noncoding RNA lncRNA-ATB in papillary thyroid cancer. Eur Rev
Med Pharmacol Sci. 21:3239–3246. 2017.PubMed/NCBI
|
|
9
|
Guo Y, Zhang P, Sheng Q, Zhao S and
Hackett TA: lncRNA expression in the auditory forebrain during
postnatal development. Gene. 593:201–216. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang F, Chen W, Peng J, Li Y, Zhuang Y,
Zhu Z, Shao C, Yang W, Yao H and Zhang S: lncRNA PVT1 triggers
Cyto-protective autophagy and promotes pancreatic ductal
adenocarcinoma development via the miR-20a-5p/ULK1 Axis. Mol
Cancer. 17:982018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun C, Luan S, Zhang G, Wang N, Shao H and
Luan C: CEBPA-mediated upregulation of the lncRNA PLIN2 promotes
the development of chronic myelogenous leukemia via the GSK3 and
Wnt/β-catenin signaling pathways. Am J Cancer Res. 7:1054–1067.
2017.PubMed/NCBI
|
|
12
|
Ye B, Liu B, Yang L, Zhu X, Zhang D, Wu W,
Zhu P, Wang Y, Wang S, Xia P, et al: lncKdm2b controls self-renewal
of embryonic stem cells via activating expression of transcription
factor Zbtb3. EMBO J. 37(pii): e971742018.PubMed/NCBI
|
|
13
|
Zheng JL, Sun J, Zhang H and Zhang Y: Role
of microRNA and lncRNA in lens development and cataract formation.
Zhonghua Yan Ke Za Zhi. 54:390–395. 2018.(In Chinese). PubMed/NCBI
|
|
14
|
Guo CJ, Zhang W and Gershwin ME: Long
noncoding RNA lncKdm2b: A critical player in the maintenance of
group 3 innate lymphoid cells. Cell Mol Immunol. 15:5–7. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu B, Ye B, Yang L, Zhu X, Huang G, Zhu
P, Du Y, Wu J, Qin X, et al: Long noncoding RNA lncKdm2b is
required for ILC3 maintenance by initiation of Zfp292 expression.
Nat Immunol. 18:499–508. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiang Y, Huang Y, Sun H, Pan Y, Wu M and
Zhang J: Deregulation of miR-520d-3p promotes hepatocellular
carcinoma development via lncRNA MIAT regulation and EPHA2
signaling activation. Biomed Pharmacother. 109:1630–1639. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song Y, Zou L, Li J, Shen ZP, Cai YL and
Wu XD: lncRNA SNHG8 promotes the development and chemo-resistance
of pancreatic adenocarcinoma. Eur Rev Med Pharmacol Sci.
22:8161–8168. 2018.PubMed/NCBI
|
|
18
|
Yu Y, Shen HM, Fang DM, Meng QJ and Xin
YH: lncRNA HCP5 promotes the development of cervical cancer by
regulating MACC1 via suppression of microRNA-15a. Eur Rev Med
Pharmacol Sci. 22:4812–4819. 2018.PubMed/NCBI
|
|
19
|
Jiang L, Wu Z, Meng X, Chu X, Huang H and
Xu C: lncRNA HOXA-AS2 facilitates tumorigenesis and progression of
papillary thyroid cancer through modulating miR-15a-5p/HOXA3 axis.
Hum Gene Ther. 30:618–631. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang W, Zhan H, Jiao Y, Li S and Gao W: A
novel lncRNA-miRNA-mRNA network analysis identified the hub lncRNA
RP11-159F24.1 in the pathogenesis of papillary thyroid cancer.
Cancer Med. 7:6290–6298. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang XM, Liu Y, Fan YX, Liu Z, Yuan QL,
Jia M, Geng ZS, Gu L and Lu XB: lncRNA PTCSC3 affects drug
resistance of anaplastic thyroid cancer through STAT3/INO80
pathway. Cancer Biol Ther. 19:590–597. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu X, Yan Y, Li H, Ji N, Yu T, Huang Y,
Shi W, Gao L, Ma L and Hu Y: DNA copy number gain-mediated lncRNA
LINC01061 upregulation predicts poor prognosis and promotes
papillary thyroid cancer progression. Biochem Biophys Res Commun.
503:1247–1253. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gu Y, Feng C, Liu T, Zhang B and Yang L:
The downregulation of lncRNA EMX2OS might independently predict
shorter recurrence-free survival of classical papillary thyroid
cancer. PLoS One. 13:e02093382018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Feng L, Yang B and Tang XD: Long noncoding
RNA LINC00460 promotes carcinogenesis via sponging miR-613 in
papillary thyroid carcinoma. J Cell Physiol. 234:11431–11439. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y, Hu J, Zhou W and Gao H: lncRNA
FOXD2-AS1 accelerates the papillary thyroid cancer progression
through regulating the miR-485-5p/KLK7 axis. J Cell Biochem. Nov
19–2018.(Epub ahead of print). doi: 10.1002/jcb.28072.
|
|
26
|
Zhu P, Wang Y, Wu J, Huang G, Liu B, Ye B,
Du Y, Gao G, Tian Y, He L and Fan Z: lncBRM initiates YAP1
signalling activation to drive self-renewal of liver cancer stem
cells. Nat Commun. 7:136082016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xi J, Feng J and Zeng S: Long noncoding
RNA lncBRM facilitates the proliferation, migration and invasion of
ovarian cancer cells via upregulation of Sox4. Am J Cancer Res.
7:2180–2189. 2017.PubMed/NCBI
|
|
28
|
Li R, Zhu H, Yang D, Xia J and Zheng Z:
Long noncoding RNA lncBRM promotes proliferation and invasion of
colorectal cancer by sponging miR-204-3p and upregulating TPT1.
Biochem Biophys Res Commun. 508:1259–1263. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
DeLellis RA and Williams ED: Tumours of
the thyroid and parathyroid. World Health Organization
Classification of Tumours. Pathology and Genetics of Endocrine
Organs. IARC Press; Lyon: pp. 58–70. 2004
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Saini S, Maker AV, Burman KD and Prabhakar
BS: Molecular aberrations and alterations in signaling cascades
implicated in the pathogenesis of anaplastic thyroid cancer.
Biochim Biophys Acta Rev Cancer. Dec 31–2018.(Epub ahead of print).
doi: 10.1016/j.bbcan.2018.12.003. PubMed/NCBI
|
|
32
|
Brajic A, Franckaert D, Burton O,
Bornschein S, Calvanese AL, Demeyer S, Cools J, Dooley J, Schlenner
S and Liston A: The Long Non-coding RNA Flatr Anticipates Foxp3
expression in regulatory T cells. Front Immunol. 9:19892018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xia F, Chen Y, Jiang B, Du X, Peng Y, Wang
W, Huang W, Feng T and Li X: Long noncoding RNA HOXA-AS2 promotes
papillary thyroid cancer progression by regulating
miR-520c-3p/S100A4 pathway. Cell Physiol Biochem. 50:1659–1672.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang N, Duan H, Zhang C, Zhou Y and Gao R:
The LINC01186 suppresses cell proliferation and invasion ability in
papillary thyroid carcinoma. Oncol Lett. 16:5639–5644.
2018.PubMed/NCBI
|
|
35
|
Palmieri F: The mitochondrial transporter
family SLC25: Identification, properties and physiopathology. Mol
Aspects Med. 34:465–484. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fernandez HR, Gadre SM, Tan M, Graham GT,
Mosaoa R, Ongkeko MS, Kim KA, Riggins RB, Parasido E, Petrini I, et
al: The mitochondrial citrate carrier, SLC25A1, drives stemness and
therapy resistance in non-small cell lung cancer. Cell Death
Differ. 25:1239–1258. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bhalla K, Hwang BJ, Dewi RE, Ou L, Twaddel
W, Fang HB, Vafai SB, Vazquez F, Puigserver P, Boros L and Girnun
GD: PGC1α promotes tumor growth by inducing gene expression
programs supporting lipogenesis. Cancer Res. 71:6888–6898. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chi H, Yang R, Zheng X, Zhang L, Jiang R
and Chen J: lncRNA RP11-79H23.3 functions as a competing endogenous
RNA to regulate PTEN expression through sponging hsa-miR-107 in the
development of bladder cancer. Int J Mol Sci. 19:25312018.
View Article : Google Scholar
|
|
39
|
Cui S, Yang X, Zhang L, Zhao Y and Yan W:
lncRNA MAFG-AS1 promotes the progression of colorectal cancer by
sponging miR-147b and activation of NDUFA4. Biochem Biophys Res
Commun. 506:251–258. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hao Y, Yang X, Zhang D, Luo J and Chen R:
Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits
migration and invasion through Epithelial-Mesenchymal-Transition in
lung cancer. Gene. 608:1–12. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Long J, Xiong J, Bai Y, Mao J, Lin J, Xu
W, Zhang H, Chen S and Zhao H: Construction and Investigation of a
lncRNA-associated ceRNA regulatory network in cholangiocarcinoma.
Front Oncol. 9:6492019. View Article : Google Scholar : PubMed/NCBI
|
